Sign in
4

Changes in Ownership

HCW Biologics Inc. Filed Acc 0001209191-21-066900

Chief Financial Officer acquired 27,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Byam Rebecca · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-11-23 Exercise or conversion : show line 1 in the form +27,000 $0.14 $3,780 89,000 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-11-23 Exercise or conversion : show line 2 in the form Stock Option Grant (Right to Buy) −27,000 80,999 D
Loading xslF345X03/doc4.xml…